Health news
Ibsrela® (tenapanor) is now available for the treatment of irritable bowel syndrome with constipation (IBS-C) in adults. Ibsrela is a locally-acting inhibitor of the sodium/hydrogen exchanger 3 (NHE3), an antiporter expressed on the apical surface…
The Food and Drug Administration (FDA) has granted Fast Track designation to AXA1125 for the treatment of nonalcoholic steatohepatitis (NASH) with liver fibrosis. AXA1125 is an orally active mixture of amino acids (endogenous metabolic modulator…
The Food and Drug Administration (FDA) has granted Orphan Drug designations to benralizumab for the treatment of eosinophilic gastritis and eosinophilic gastroenteritis, as well as Fast Track designation for the treatment of eosinophilic gastritis with…
The Food and Drug Administration (FDA) has granted Fast Track designation to LPCN 1144 for the treatment of noncirrhotic nonalcoholic steatohepatitis (NASH). LPCN 114 is an oral prodrug of bioidentical testosterone. The designation is supported…
Pharmacotherapies used in the treatment of nonalcoholic steatohepatitis (NASH) were compared in a recent systematic review and network meta-analysis published in Alimentary Pharmacology & Therapeutics. Although NASH is a common cause of chronic liver disease,…
© 2005-2021 Top-Meds - All rights reserved. Our website services, content, and products are for informational purposes only. Top-Meds does not provide medical advice, diagnosis, or treatment. | Medical News 2021